However, it has to be noted that ERβ, which is expressed in all breast cancer molecular subtypes and in the majority of breast cancer stem cells, was recently proposed as a novel therapeutic target to specifically hit stem cells [76]. Here, ESR2 is linked to breast carcinoma.